Reaction of plasma hepatocyte growth factor levels in non-small cell lung cancer patients treated with EGFR-TKIs. (Q54628931)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21128242%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Reaction of plasma hepatocyte growth factor levels in non-small cell lung cancer patients treated with EGFR-TKIs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21128242%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21128242%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1

Hidenori Tanaka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21128242%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

8

Masayuki Noguchi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21128242%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Tatsuo Kimura

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21128242%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Shinzoh Kudoh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21128242%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Shigeki Mitsuoka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21128242%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Tetsuya Watanabe

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21128242%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Keisei Tachibana

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21128242%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Seiji Yano

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21128242%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Kazuto Hirata

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21128242%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

26 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21128242%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21128242%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21128242%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21128242%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1410-1416

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21128242%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics, 2002

17 January 2020

cites work

1 reference

21 January 2018

Cancer statistics, 2007

1 reference

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

21 January 2018

1 reference

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

21 January 2018

1 reference

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

21 January 2018

1 reference

Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations.

21 January 2018

1 reference

Met, metastasis, motility and more

21 January 2018

1 reference

Stromal fibroblasts in cancer initiation and progression

21 January 2018

1 reference

Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer

21 January 2018

1 reference

Scatter factors and invasive growth

21 January 2018

1 reference

ELISA and multiplex technologies for cytokine measurement in inflammation and aging research

21 January 2018

1 reference

Hepatocyte growth factor and c-Met (HGF/c-Met) in adenoid cystic carcinoma of the human salivary gland

21 January 2018

1 reference

Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

21 January 2018

1 reference

MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients.

21 January 2018

1 reference

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

21 January 2018

1 reference

Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy

21 January 2018

1 reference

Crosstalk to stromal fibroblasts induces resistance of lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors

21 January 2018

1 reference

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

21 January 2018

1 reference

Screening for epidermal growth factor receptor mutations in lung cancer

21 January 2018

1 reference

Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer

21 January 2018

1 reference

Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations

21 January 2018

1 reference

EGFR mutation and response of lung cancer to gefitinib

21 January 2018

1 reference